25 / 182
Newcustomers&sales channels
These include further contract manufacturing opportunities
in the OTC and Prescription Divisions. Further extending our
detailing presence in the OTC Division to dispensing doctors.
Export opportunities in the Consumer and OTC Divisions.
Innovation
Improve access to our pipeline at the MCC in the Prescription,
OTC and Hospital Divisions. In the Consumer and OTC Divisions
extend formulations, pack variants and line extensions within
our analgesia, energy and anti-histamine product range.
Extracting
manufacturing
efficiencies
and increasing
throughput atWadeville
and Clayville
Maintaining
full regulatory
compliance
in the factories and
distribution centres, and
no product recalls
Reinforcing the culture of
responsibility,
accountability
and fun
at work
FIVE
SIX
THREE
ONE
FOUR
TWO
OUR STRATEGY TO SUSTAIN VALUE
(continued)
| 21
Integrated Report 2016